Mitochondria are highly dynamic organelles. Through a large-scale in vivo RNA interference (RNAi) screen that covered around a quarter of the Drosophila melanogaster genes (4000 genes), we identified 578 genes whose knockdown led to aberrant shapes or distributions of mitochondria. The complex analysis revealed that knockdown of the subunits of proteasomes, spliceosomes, and the electron transport chain complexes could severely affect mitochondrial morphology. The loss of Dhpr, a gene encoding an enzyme catalyzing tetrahydrobiopterin regeneration, leads to a reduction in the numbers of tyrosine hydroxylase neurons, shorter lifespan, and gradual loss of muscle integrity and climbing ability. The affected mitochondria in Dhpr mutants are swollen and have fewer cristae, probably due to lower levels of Drp1 S-nitrosylation. Overexpression of Drp1, but not of S-nitrosylation-defective Drp1, rescued Dhpr RNAi-induced mitochondrial defects. We propose that Dhpr regulates mitochondrial morphology and tissue homeostasis by modulating S-nitrosylation of Drp1. Large-scale RNAi screen identified Dhpr as a regulator of mitochondrial morphology and tissue homeostasis. Sci. Adv. 5, eaax0365 (2019).
INTRODUCTION
Mitochondria are highly dynamic organelles participating in energy production, metabolism, and apoptosis (1) . The fusion, fission, trans port, and degradation of mitochondria shape their morphology and further affect their function. Mitochondrial morphology changes have been observed in many disease conditions, such as neurodegenera tive diseases (2) .
Many key molecules that regulate mitochondrial fusion, fission, transport, and mitophagy were identified (1) . Three large guanosine triphosphatases (GTPases), MFN1/2, and OPA1 are required for the fusion of the mitochondrial outer and inner membrane (1) . In addi tion, MitoPLD, a member of the phospholipase D (PLD) superfamily, and Miga1/2 (3), proteins with unknown functional domains, anchor to the outer mitochondrial membrane and participate in the fusion process. The loss of these proteins led to the fragmentation of mitochon dria. In mammalian cells, OPA1 activity is regulated through pro teolytic cleavage by inner membrane proteases Yme1L and Oma1. The presence of the long and short forms of OPA1 is required for proper fusion of the inner membrane of mitochondria. The fission of mitochondria is mediated by a dynaminlike large GTPase, Drp1. Drp1 is recruited by receptor proteins such as Mff, Fis1, MiD49, and MiD50 to the fission sites marked by the mitochondrial endoplas mic reticulum (ER) contacts. The activity of Drp1 could be modu lated by phosphorylation, Snitrosylation, SUMOylation, and Olinked Nacetylglucosamine glycosylation. Mitochondria are actively trans ported along the microtubules inside cells. The motor proteins such as kinesin and dynein mediate the anterograde and retrograde trans port. Interactions between Miro proteins and Milton proteins serve as adaptors to link kinesin to the mitochondria. In neurons, syntaphi lin anchors axonal mitochondria to microtubules and regulates axonal mitochondrial transport together with Miro and Milton. The degra dation of mitochondria is mediated by mitophagy (4) . The proteins encoded by the Parkinson's disease (PD)-related genes Pink1 and Parkin sense the mitochondrial damage, mark the damaged mitochon dria, and mediate their degradation by the autophagy pathway. In flies, the loss of Pink1 and park (fly ortholog of Parkin) led to a marked change in mitochondrial morphology in multiple tissues. The mitochondria became swollen and exhibited loss of the cristae. In mammals, Nix serves as a mitophagy receptor during red blood cell maturation. FUNDC1 is another mitophagy receptor that functions in hypoxiamediated mitophagy.
It has been shown that mitochondrial morphology changes are highly associated with their metabolic status (5) . However, a systematic analysis of the factors required for mitochondrial morphology maintenance under in vivo conditions is still lacking. To understand the regulatory network of the mitochondrial mor phology, we performed a systematic screen using the RNA interfer ence (RNAi) strategy in fly fat body tissues. The fly fat body is a tissue that resembles liver and adipose tissues in human. This tissue is a great model system to study cellular organelles because it has singlelayered cells, and the cell size is large. The mitochondrial morphology in fat body is stereotyped and shows very little change between different experiments. In addition, the mitochondrial morphology did not change significantly in the fat bodies from early thirdinstar (82 hours after egg laying) to mid-thirdinstar larvae (96 hours after egg laying; fig. S2 , A to D). Therefore, even if there is a slight developmental delay, it will not significantly affect mitochondrial morphology. Using this in vivo system, we screened 4146 RNAi lines (6) corresponding to 4221 genes (a few RNAi lines target common regions shared by multiple genes) and identified 578 genes required for proper mitochondrial morphology maintenance. We further carried out a complex analysis and established a network that regulates mitochondrial morphology. In addition, we demon strated that dihydropteridine reductase (Dhpr) played critical roles in maintaining mitochondrial morphology by regulating the mod ification of Drp1. Our study not only serves as a rich source of information to study mitochondrial morphology but also sheds light on the molecular mechanisms underlying the diseases caused by the loss of Dhprrelated genes.
RESULTS

Mitochondrial morphology screen in fly fat body tissues
To systematically identify genes essential for the maintenance of mito chondrial morphology, we conducted a largescale RNAi screen covering about 25% of the fly genes in the fly fat body tissues. We knocked down gene expression by driving UASdsRNA or UAS shRNA expression in the fat body with CgGal4, a fat body expressing Gal4, and marked the mitochondria with mitoGFP. The dissected early thirdinstar larvae fat bodies were fixed, and the mitochondrial mor phology was examined using confocal microscopy by experienced re searchers in a doubleblind manner (Fig. 1A) .
In total, we screened 4146 RNAi lines from the TRiP (Transgenic RNAi Project) collection (6) (table S1), which corresponded to 4221 individual genes. We found that 598 lines targeting 578 genes caused aberrant mitochondrial morphology (table S2) . Then, the images of the positive hits were examined and categorized by two independent researchers in a doubleblind manner (Fig. 1B) . Hits with the follow ing characteristics were categorized without further measurements: (i) The ones with mitochondria that showed apparent enlarged bubble like shape were categorized as "Swollen" (5.71%, n = 33; Fig. 1, B and D, and table S2), (ii) the one hit that showed almost no green fluo rescent protein (GFP) signal was categorized as "No signal" (0.17%, n = 1; Fig. 1 , B and E, and table S2), and (iii) the ones with fuzzy mitochondria that clustered together and the outline of individual mitochondria that cannot be distinguished were categorized as "Fuzzy and clustered" (1.90%, n = 11; Fig. 1, B and F, and table S2). The rest of hits with large fluorescence patches or puncta were picked out, and the diameters of the largest patches or puncta from at least three independent images for each genotype were measured. The ones with average diameter larger than 2 m (about five times of the average diameter of the mitochondrion in the wildtype fat body tissues) were singled out. For these hits, there were distinguishable mitochondria outside of the large fluorescence patches or puncta. We then selected an area of 64 m 2 outside of the patches and measured the length of the mitochondria. If the average mitochondrial length in these tissues was longer than that in the wild type (about 2 m), these hits were categorized as "Tubular and clustered" (3.46%, n = 20; Fig. 1 , B and G, and table S2). If the average mitochondrial length in these tissues was shorter than that in the wild type, these hits were catego rized as "Fragmented and clustered" (11.94%, n = 69; Fig. 1, B and H, and table S2). If the average mitochondrial length in these tissues was comparable to that in the wild type, these hits were categorized as "Clustered" (0.87%, n = 5; Fig. 1, B and I, and table S2). For the hits that do not belong to above categories, an area of 64 m 2 was selected randomly (avoid nuclear region) and the length of mitochon dria was measured. If the average mitochondrial length in these tis sues was shorter than that in the wild type (L < 2 m, P < 0.05), the hits were categorized as "Fragmented" (61.25%, n = 354; Fig. 1 , B and J, and table S2). If the average mitochondrial length in these tissues was longer than that in the wild type (L > 2 m, P < 0.05), the hits were categorized as "Tubular" (14.71%, n = 85; Fig. 1, B and K, and table S2).
Several genes necessary for controlling mitochondrial morphology were identified in our screen, suggesting that our screen strategy is reliable ( Fig. 1 , L to V). Some identified genes encode the core ma chinery regulating mitochondrial fission or fusion, such as Drp1 (7), Marf (fly ortholog of MFN1/2) (8), Opa1 (9), and zuc (fly ortholog of MitoPLD) (10) . In our screen, knockdown of Drp1 (Fig. 1L ) led to swollen mitochondria, and RNAi of Marf (Fig. 1M ), Opa1 (Fig. 1N ), and zuc ( Fig. 1O ) resulted in fragmented mitochondria. Some iden tified genes indirectly regulated mitochondrial fusion and fission by modulating the transcription or modification of the core fusionfission machinery. It has been reported that activation of Yorkie (Yki) causes transcriptional upregulation of genes that regulate mitochondrial fusion, such as Opa1 and Marf (11) . In our screen, we found that when warts (wts) (Fig. 1P ), a gene that encodes the terminal kinase that phosphorylates and inhibits Yki, was knocked down in fat body tissues, a majority of the mitochondria became tubular. We also identified the YME1L gene, whose mammalian ortholog encodes a protease that involves proteolytic processing of OPA1 (12) . In our screen, the reduction of YME1L led to fragmented and clustered mitochondria ( Fig. 1Q ). In addition to the genes required for proper mitochondrial fusion and fission, we identified genes required for cristae organization (Chchd3) ( Fig. 1R) (13) , mitochondria positioning (MSP300) ( Fig. 1S ) (14) , mitochondria transport (milt) ( Fig. 1T) (15) , and mitophagy (Pink1 and park) ( Fig. 1 , U and V) (16) . All of these genes were reported to be required for maintaining mitochondrial morphology through different means, suggesting that our screen could recover genes that regulate mitochondrial morphology by different pathways.
Several RNAi screens that have used the same collection of RNAi lines suggested that the offtarget rates of this collection were low. Among 578 genes identified, the RNAi lines corresponding to 562 genes were predicted to have no offtarget (17) . Twentythree genes turned out to have more than one independent short hairpin-mediated RNAi (shRNAi) lines. For 17 genes, the independent RNAi lines tar geting a single gene produced progenies with similar phenotypes when they were crossed with Cg-Gal4 flies (table S3) . To further validate the fidelity of the screen, we obtained independent RNAi lines for another 130 hits and performed the same experiments, and the phe notypes were confirmed for 121 genes, suggesting again that our data sets are reliable (table S3) .
Mitochondrial morphology regulatory networks
To understand the regulatory network of mitochondrial morpholo gy, we used the online software COMPLEAT and the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis to identify the protein complexes (18) . Combined with manual data mining, we generated a geneprotein interaction network for the genes identified in this screen (fig. S1).
In total, we identified 312 protein complexes required for mito chondrial morphology maintenance (table S4) . The major complexes identified were those participating in processes such as mitochondria respiration and metabolism, RNA splicing, and proteolysis (table S5) .
In addition to the molecules such as Drp1, Marf, OPA1, and Zuc that are directly involved in mitochondrial fission and fusion, we also identified multiple molecules that encode subunits of the electron transport chain (ETC) complexes or components required for the assembly of the mitochondrial respiratory chain complexes (table  S5) . In total, we identified 16 subunits of mitochondrial complex I, two proteins that are required for complex I assembly, one subunit of complex II, two subunits of complex III, one subunit of complex IV, two factors required for complex IV assembly, and five subunits of complex V. We also identified an enzyme cytochrome c heme lyase (Cchl) that is involved in the synthesis of cytochrome c, a soluble elec tron carrier that functions in electron transport between complexes III and IV (table S5) (19) . The reduction of the expression of many of these proteins often led to severe swollen mitochondria ( Fig. 2 , A to J). The transmission electron microscopy (TEM) analysis of The typical mitochondrial morphologies in fat body tissues were shown for each phenotype category. (L to V) Genes that were reported to regulate mitochondrial morphology were identified in this screen. The mitochondrial morphology in the fat body cells with the indicated gene knockdown is shown. Scale bars, 5 m. Green signals were mitoGFP signals to indicate the mitochondrial morphology. Blue signals were nuclear 4′,6-diamidino-2-phenylindole (DAPI) staining. The boxed region in each image was enlarged in the inset to show the typical mitochondrial morphology. The phenotype category for each genotype was listed on the top of the image. the fat body tissues showed enlarged mitochondria with few cristae (Fig. 2 , M to P, R, and S). We found that the knockdown of CTPsyn, a gene encoding cytidine triphosphate (CTP) synthase (20) , led to a swollen mitochondrial phenotype that was very similar to the pheno type observed in the tissues with a reduction in respiration chain complex components (Fig. 2 , K and Q to S). Two independent RNAi lines were used to confirm the phenotypes (Fig. 2 , K and L). We de tected the reduction in adenosine 5′triphosphate (ATP) level ( Fig. 2T ) and the increase in reactive oxygen species (ROS) production ( Fig. 2 , U to X) when CTPsyn expression was reduced, suggesting that CTPsyn might regulate mitochondrial morphology via regulation of ETC activities.
In this screen, we also identified other genes encoding proteins localized in the mitochondria, including genes regulating mitochon drial DNA and protein synthesis [ Peroxisomes are organelles that are closely related to mitochon dria. In this screen, we identified multiple genes encoding proteins that were required for proper peroxisome functions. Hmgcr is a gene required for nonsterol isoprenoid production ( fig. S2X ). The loss of these genes also resulted in abnormal mitochondrial morphology.
Twentyseven members of nuclear mRNA splicing complexes and 16 proteins in proteolysis complexes were identified in our screen, suggesting that mRNA splicing and proteolysis are critical for mito chondrial morphology [figs. S3 (A to Q) and S4 (A to Z) and table S5].
Members that belong to the same complex tended to cause similar phenotypes when their functions were blocked. For example, the re duction in the expression of genes encoding proteasome subunits [such as Rpn1 ( In this screen, we identified 27 genes encoding spliceosome com ponents ( fig. S4 , A to Z″, and table S5). The knockdown of some of these genes resulted in very similar mitochondrial morphology defects. The KEGG pathway analysis (23) indicated that four (Got1, Hgo, GstZ2, and Faa) of five enzymes participating in the catabolism of tyrosine were required for proper mitochondrial morphology ( fig. S5A ). When their expression was reduced, mitochondria became fragmented and sometimes clustered ( fig. S5 , B to F). In addition, the enzyme required for hydrolyzing tyrosine to ldopa was also necessary for main taining mitochondrial morphology ( fig. S5G ). Furthermore, we found that lysine metabolism could modulate mitochondrial morphology ( fig. S5H ). Knocking down genes such as LKRSDH or CG9629 that encode enzymes that participate in lysine degradation affected mito chondrial morphology (fig. S5, I to K). Genes encoding enzymes involved in the synthesis of carnitine from trimethyllysine and en zymes methylating protein lysine residues were also identified in our screen (fig. S5, K to Q). Most of these proteins mentioned above are not localized on the mitochondria. Therefore, the mitochondrial morphology changes in the tissues with those proteins reduced were likely due to indirect effects.
Loss of Dhpr phenocopies the loss of PD-related genes Pink1 and park
We found that the loss of PDrelated genes, Pink1 and park, led to big mitoGFP puncta formed inside fat body tissues in our screen ( Fig. 3 , A to C and I). Two other genes' loss could also result in a very sim ilar but less severe mitochondrial phenotype. Those two genes were ben and Dhpr (Fig. 3 , D, E, and I). Ben encodes an E2 whose mammalian ortholog functions in the same pathway with Pink1 and parkin to reg ulate the mitophagy process (24) . Dhpr encodes a dihydropteridine reductase, which catalyzes the reduced form of nicotinamide adenine dinucleotide (NADH)-mediated regeneration of tetrahydrobiopterin (BH4) from dihydrobiopterin (BH2) (25) . BH4 functions as a cofactor to convert amino acids such as phenylalanine, tyrosine, and tryptophan to precursors of dopamine and serotonin. It also serves as a catalyst for the production of nitric oxide (NO) (25) . Overexpression of the complementary DNA (cDNA) of Dhpr could rescue the mitochon drial defects caused by Dhpr RNAi (Fig. 3 , F and I), suggesting that the mitochondrial defects were caused by the reduction of Dhpr. TEM analysis indicated that many mitochondria are enlarged and have less cristae in Dhpr RNAi fat body tissues ( Fig. 3 , G, H, J, and J′), which is very similar to what has been observed in Pink1/park mu tants. We also examined the markers for Golgi (ManII; fig SKLGFP puncta in Dhpr RNAi tissues are larger than that in the control tissues ( fig. S6, B and E, and G and H). Because peroxisomes are closely related to mitochondria, Dhpr might regulate the com mon regulating machinery shared by both organelles.
We then made Dhpr mutant flies using the CRISPRCas9 tech nique (26) . We identified two alleles, Dhpr and Dhpr 42-5 , with small deletions that resulted in premature stop of the translations ( fig. S6I ). Both alleles have similar phenotypes, and we therefore focused on the allele Dhpr for detailed analysis. Some Dhpr flies could survive to adulthood, are fertile, and have normal wing postures ( fig. S6J ). However, it is very difficult to maintain a homozygous mutant stock. In addition, the heterozygous stock does not produce homozygous animals in a Mendelian ratio [41% heterozygous flies (Dhpr 17-4 /TM6B) and 1% homozygous (Dhpr 17-4 /Dhpr ) mutants survived to adult hood (n = 300)], suggesting that many . We further exam ined the thin section of the muscles using TEM. In Dhpr mutant flies, some of the muscle fibers were lost or disorganized (Fig. 3 , K′ and L′). In the affected muscle fragments, mitochondria were swollen and had less cristae ( Fig. 3 , K′, L′, and P). These muscle defects could be rescued by a genomic fragment containing only Dhpr (Fig. 3 , N, N′, O, and P), indicating that the loss of Dhpr is responsible for the phenotypes. Using antityrosine hydroxylase (TH) antibody stain ing, we also found that, in 35dayold Dhpr 17-4 mutants, the num bers of TH neurons in the dorsomedial (DM), dorsolateral (DL) 1, and posteriomedial (PM) regions were reduced ( Fig. 3 , Q, R, and T). To examine whether there are mitochondrial defects before the loss of the TH neurons, we examined the mitochondrial morphology in the TH neurons of the 5dayold wildtype or mutant animals. When knocking down Dhpr expression specifically in TH neurons us ing Ple-Gal4, we found that mitoGFPlabeled mitochon dria in most of the TH neurons became enlarged and clustered ( Fig. 3 , U, V, and X). Similar phenotypes were also observed in the agematched Pink1 [B9] flies (Fig. 3 , S and T, and W and X).
Pink1/park functions in parallel with Dhpr
Because Pink1 and Dhpr mutants have similar phenotypes (Fig. 3, B and E, L and M, R and S, and V and W), we suspected that they might function in a same pathway to regulate mitochondrial morphology and tissue homeostasis. Therefore, we performed the epistasis analysis between Dhpr, Pink1, and park. In fly fat body tissues, Dhpr RNAi leads to big mitochondrial puncta formed inside cells (Fig. 4, A and B) . Pink1 or park overexpression alone does not cause marked mitochon drial morphology changes (Fig. 4, C and D) . However, when Pink1 or park was overexpressed in Dhpr RNAi tissues, the big mitochon drial puncta disappeared, and the mitochondria looked grossly normal ( Fig. 4, E, F, and I) . Fat body tissues with Pink1 RNAi accumulate large mitochondrial puncta (Fig. 3B) . The mitochondrial puncta re mained when Dhpr was overexpressed in Pink1 RNAi tissues (Fig. 4 , G to I). These data suggested that Dhpr functions either upstream or in parallel with Pink1/park. In the flight muscles, Dhpr RNAi re sults in disorganized muscle fibers in some muscle fragments ( Fig. 4 , J, K, and P) in the 3dayold animals. Some of the mitochondria have less cristae ( Fig. 4 , J′, K′, and Q). The toluidine blue staining of the thick section of the thorax indicated that Pink1 or park overexpression could rescue the muscle integrity of the Dhpr RNAi animals (Fig. 4 , K to P). However, the TEM analysis indicated that Pink1 overexpres sion in wildtype animals slightly reduced the mitochondrial size and led to mild cristae abnormality ( Fig. 4 , L′, Q, and Q′). The overex pression of Pink1 also reduced the mitochondrial size of the Dhpr RNAi animals (Fig. 4 , M′ and Q′). When Pink1 was overexpressed in Dhpr RNAi muscles, the mitochondrial cristae density was increased compared with that in Dhpr RNAi muscles ( Fig. 4 , K′, M′ and Q). park overexpression in wildtype animals did not cause any obvious defects in muscles (Fig. 4, N and N′) . When park was over expressed in Dhpr RNAi muscles, although the mitochondria in some muscle fragments look normal (Fig. 4, O and O′) , those in the other muscle fragments still have defective cristae morphology (Fig. 4 , O″ and Q). Although it could partially rescue the mitochondrial morpholo gy, Pink1 and park overexpression could not rescue the climbing defects caused by the reduction of Dhpr in 3dayold flies ( fig. S7A ). We also examined the muscle integrity and the mitochondrial mor phology in 35dayold flies ( fig. S7, B to J). The muscle degeneration in the 35dayold Dhpr RNAi flies was more severe than that in the 3dayold ones ( Fig. 4K and fig. S7C ), indicating that the muscle degeneration is progressing with aging. The size of the mitochondria became irregular, and the cristae organization was severely damaged in the old Dhpr RNAi animals ( fig. S7 , C′, C″, and I). When Pink1 was overexpressed, the muscle fibers look grossly normal in 35day old animals ( fig. S7 , D and H), but the mitochondria become round and the spaces between mitochondria and the myotubes are larger than that in controls ( fig. S7 , B′ and D′). Pink1 overexpression could largely rescue muscle fiber organization in Dhpr RNAi animals ( fig.  S7, F and H) . However, the cristae in some mitochondria were not well organized, and mitochondria sizes were irregular ( fig. S7 , F′, F″, I, and J). When Park was overexpressed, the overall muscle organization was normal in 35dayold animals ( fig. S7, E and H) . However, the distribution of mitochondria was different from that in wildtype controls ( fig. S7 , B′ and E′). When park was overex pressed in Dhpr RNAi muscles, although the overall muscle degen eration looks less severe than that in Dhpr RNAi alone animals, many of the muscle fragments still have small lesions ( fig. S7, G and H) . A small fraction of mitochondria has defective cristae organization, and the size of the mitochondria is variable ( fig. S7 , G′, G″, I, and J). These data suggest that the overexpression of Pink1 and park could partially rescue the muscle defects caused by Dhpr RNAi in both young and old animals. We then knocked down Dhpr expression in Pink1 [B9] animals and examined the muscle integrity in the 3dayold animals. In the young Pink1 [B9] animals, many muscle fibers are disorganized, but there are some fibers that still look normal (Fig. 4, R and T) . Similarly, mitochondria with less cristae exist in the Pink1 [B9] mutant muscle fibers (Fig. 4R″) , and there are also normallooking mitochondria with dense cristae resembling those of the wildtype animals ( Fig. 4R′) . Dhpr knockdown in the muscle of Pink1 [B9] mutant animals significantly enhanced the muscle defects of the Pink1 [B9] mutant animals ( Fig. 4 , S, S′, T, and U). In these animals, the flight muscle fibers in the 3dayold animals are severely disorganized, and all the mitochondria have abnormal cristae. These data suggested that Dhpr functions in parallel with Pink1/park to regulate mitochondrial morphology.
Reduction of Nos enhanced mitochondrial defects caused by Dhpr RNAi
The gene products of Dhpr's human ortholog QDPR are listed in the inventory of proteins localized to mitochondria (MitoMax and MitoCarta) (27, 28) . We therefore investigate whether Dhpr localizes on the mitochondria. We expressed V5tagged Dhpr in S2 cells. Dhpr showed a diffused cytosolic pattern with no specific colocalization with mitochondria ( fig. S7 , K, K′, and K″). To avoid the possibility that the diffused pattern of Dhpr is due to overexpression, we trans fected a genomic fragment with Dhpr tagged at the C terminus with V5 into S2 cells and examined Dhpr's pattern with antiV5 staining. Although the expression level was much lower than the overexpres sion experiments, Dhpr was still diffused inside the cell ( fig. S7 , L, L′, and L″). We also examined Dhpr pattern in the fat body tissues with the expression of a genomic rescue construct that had a V5 tag at the C terminus of the Dhpr coding sequence. Again, there was no specific mitochondrialocalized V5 signals, and the overall pattern of Dhpr was diffused ( fig. S7 , M, M′, and M″). To examine whether quinoid dihydropteridine reductase (QDPR), the mammalian coun terpart of Dhpr, was localized specifically on the mitochondria, we cotransfected Hela cells with GFPtagged QDPR (Cterminal tag) and MitoRFP. Similar to Dhpr, QDPR also had a diffused pattern without specific mitochondrial localization ( fig. S7 , N, N′, and N″). It suggested that Dhpr might indirectly regulate mitochondrial morphology. Dhpr is an enzyme catalyzing the regeneration of BH4 from BH2. We then wanted to test whether the enzyme activity of Dhpr is required for mitochondrial integrity. QDPR is the mamma lian ortholog of Dhpr. QDPR G23D mutation is a recurrent mutation in human patients, which renders the enzyme completely inactive (29) . The 23rd glycine in QDPR corresponds to the 16th glycine in fly Dhpr ( fig. S8A ). We therefore made a transgene expressing the mutant form of Dhpr, Dhpr G16D , and expressed it in fat body and muscles alone or together with Dhpr shRNA (short hairpin RNA). As a control, the wildtype Dhpr was overexpressed in the same manner. Overexpression of wildtype Dhpr or Dhpr G16D alone did not cause obvious mitochondrial defects in both fat bodies ( Fig. 5 , A, C, D, Q, and Q′) and flight muscles ( Fig. 5 , E, G, H, and R, and E′, G′, H′, and S). Wildtype Dhpr overexpression could rescue the mitochondrial defects induced by Dhpr RNAi in both fat bodies ( Fig. 5, B , I, Q, and Q′) and flight muscles ( Fig. 5, F , M, and R, and F′, M′, and S). However, mitochondrial defects became worse when Dhpr G16D was overexpressed in Dhpr RNAi tissues (Fig. 5, B , J, Q, and Q′; F, N, and R; and F′, N′, and S), suggesting that the enzyme activity of Dhpr is required for maintaining mitochondrial morphology and that Dhpr G16D likely has weak dominant negative effects. When we assessed the climbing activity, we found that wild type but not Dhpr G16D rescued the climbing defects caused by the reduction of Dhpr (fig. S7A) .
Punch (Pu) encodes an enzyme that is required for de novo BH4 synthesis (fig. S8B ). The knockdown of Pu expression alone did not cause obvious mitochondrial morphology defects in fat body tissues ( fig. S8 , C, E, and O). However, knocking down Pu expression in Dhpr RNAi tissues greatly enhanced the mitochondrial defects caused by Dhpr RNAi alone ( fig. S8, F, O, and P) . The mitochondria became swollen and severely damaged, indicating that BH4 is critical for maintaining the proper mitochondrial morphology.
BH4 functions as a cofactor to produce NO and synthesis of the precursors of dopamine and serotonin (25) . Nitric oxide synthase (Nos) encodes a NO synthase that produces NO using arginine and con verts BH4 to BH2 at the same time ( fig. S8B ). Henna (Hn) uses BH4 as a cofactor to hydroxylate both phenylalanine to form tyrosine and tryptophan to generate the precursor for peripheral serotonin (fig.  S8B ). Pale (Ple) then uses BH4 as a cofactor to catalyze tyrosine to form ldopa (fig. S8B ). Tryptophan hydroxylase (Trh) catalyzes the conversion of tryptophan to 5hydroxytryptophan and con verts BH4 to BH2 at the same time. Trh has also a phenylalanine 4monooxygenase activity to catalyze the conversion of phenylalanine to tyrosine ( fig. S8B ). To distinguish which pathway that required BH4 is critical for mitochondrial morphology, we knocked down the ex pression of Nos, hn, ple, and Trh individually, or each together with Dhpr, and examined the mitochondrial morphology in fat bodies. The knockdown of Nos (Fig. 5 , K, Q, and Q′), hn ( fig. S8 , G, O, and P), and Trh ( fig. S8, H , O, and P) alone did not cause obvious mitochon drial defects. As mentioned before, ple knockdown led to fragmen tation of the mitochondria (fig. S8I ), a phenotype that was distinct from the phenotypes that were observed in Dhpr RNAi tissues. When we reduced the expression of Nos and Dhpr together ( Fig. 5 , L, P, and P′), the mitochondrial morphology defects were greatly enhanced ( Fig. 5, L 
Dhpr regulates mitochondrial morphology by modulating S-nitrosylation of Drp1
The big mitochondrial puncta in Pink1 and park mutant could be rescued by reducing the expression of Marf or increasing the expres sion of Drp1 (30, 31) . We therefore tested whether manipulating the expression of the key molecules regulating mitochondrial fusion or fission could modify the mitochondrial phenotypes in Dhpr RNAi tissues. The knockdown of Marf or Opa1 in Dhpr RNAi tissues re sults in increased clusters of mitochondria compared with that in the tissues with Dhpr RNAi alone ( fig. S9 , A to F, K, and L). When Myctagged Marf was overexpressed in the Dhpr RNAi tissues ( fig. S9 , H, K, and L), the size of mitochondrial puncta was greatly increased compared with that in Dhpr RNAi alone ( fig. S9, B , H, K, and L) or Marf overexpression alone ( fig. S9 , G, K, and L). We found that the overexpression of Drp1 could rescue the mitochondrial defects ob served in Dhpr RNAi fat body tissues (Fig. 6, A to D and I) . In addition, the overexpression of Drp1 also partially rescued the mitochon drial morphology defects in Dhpr, Pu or Dhpr, Nos double RNAi animals ( Fig. 5L and fig. S8 , F and M to P). The decreased Drp1 expression in tissues with Dhpr RNAi led to mitochondrial defects similar to that in Drp1 RNAi alone, and the defects were more severe compared to those in Dhpr RNAi alone (fig. S9, B and I to L). We further tested whether Drp1 overexpression could also rescue the mitochondrial defects in fly muscles. We used MefGal4 to drive the expression of UAS-Drp1 and UAS-shRNA targeting Dhpr in fly muscles and examined muscle mitochondrial morphology using TEM. Drp1 expression could rescue the defects in both the muscle fiber ( Fig. 6 , E to H and J) and mitochondria ( Fig. 6 , E′ to H′, K, and K′). Consistent with these data, Drp1 expression also rescued the climbing defects in Dhpr RNAi flies (fig. S7A ). We then tested wheth er the expression of Drp1 in Dhpr RNAi tissues was reduced. The thorax tissues from the control or Dhpr RNAi tissues were dissect ed, and the expression of Drp1 and Marf was examined by Western blot (fig. S9M ). As a control, the tubulin level was also assessed for the same samples. Unexpectedly, the Drp1 level was not reduced but slightly increased in Dhpr RNAi tissues (fig. S9, M and N) . The ex pression of Marf was not changed (fig. S9, M and N) . This suggested that Dhpr RNAi might reduce the activity, but not the level, of Drp1, and the overexpression of Drp1 could compensate for the reduction of its activity.
It has been reported that Drp1 was activated by NOmediated Snitrosylation (32) . We therefore examined whether the Snitrosylation of Drp1 (SNODrp1) was reduced in Dhpr RNAi animals. We used MefGal4 to drive the expression of Dhpr shRNA in muscles and dissected adult thorax muscle tissues for the Snitrosylation assays. We found that the knockdown of Dhpr reduced the SNODrp1 level (Fig. 6, L and L′) . It has been reported that the mammalian Drp1 was Snitrosylated at Cys 644 , a site that is conserved and corresponds to Cys 643 in fly Drp1 ( fig. S9O) (32) . To examine whether Cys 643 is the key Snitrosylation site, we expressed hemagglutinin (HA)tagged wildtype Drp1 or Drp C643A in fly muscles and examined the Snitrosylation level of the ectopically expressed Drp1. The SNODrp1 level was greatly reduced when Cys 643 was mutated to alanine (Fig. 6 , M and M′). The expression of Drp C643A transgene could not rescue Drp1 RNAi defects as the wild type does (Fig. 6 , N to Q and R), sug gesting that it is an inactive form of Drp1. We expressed this mutant form of Drp1 in fat body tissues alone or together with Dhpr shRNA. The overexpression of Drp1 C643A alone did not produce obvious mitochondrial morphology changes (Fig. 6P ). When Drp1 C643A was expressed in the Dhpr RNAi tissues (Fig. 6S) , it could not rescue the mitochondrial defects caused by the reduction of Dhpr (Fig. 6 , B, S, and I). Together, these data suggested that Dhpr regulates mitochondrial morphology by promoting the Snitrosylation of Drp1.
DISCUSSION
Several cell culture-based largescale RNAi screens have been con ducted to investigate molecules regulating Pink1/Parkinmediated mitophagy (17) . Until now, no systematical analysis of the regulatory network of mitochondrial morphology has been performed. Here, we identified 578 genes that regulate mitochondrial morphology, many of which were identified for the first time. The large number of the genes identified in this screen indicates that many cellular events are linked to the regulation of mitochondrial morphology. Because RNAi might have offtarget effects, further confirmations are needed to validate the effects of the hits.
Using COMPLEAT and the KEGG pathway analysis, we identi fied multiple important pathways and built up a network of the reg ulators of mitochondrial morphology under in vivo conditions. Some mitochondrial phenotypes, such as fragmented, fragmented and clustered, tubular, and tubular and clustered, are common pheno types. On the contrary, swollen and fuzzy mitochondria are rather specific phenotypes, and the affected genes often function in the same pathway. For example, the reduction of the expression of proteasome subunits results in fuzzy and clustered mitochondria, a phenotype that we seldom see when genes other than the ones encoding proteasome subunits were knocked down. Similarly, the reduction of the expression of ETC components often leads to the swollen mitochon dria. Therefore, these mitochondrial phenotypes might be an indica tion of the involvement of a particular pathway. In this study, we found that the loss of CTPsyn results in a mitochondrial phenotype that is very similar to the phenotype observed in tissues with a reduc tion in ETC components. The increase in ROS and reduction in ATP synthesis were also observed in CTPsyn RNAi tissues. CTPsyn forms filamentous polymers in the cytosol and is the ratelimiting enzyme for the synthesis of CTP from both the de novo and uridine salvage pathways. In flies, CTPsyn is an essential gene required for brain development. Although the biochemical activity, structure, and subcellular distribution of CTPsyn are well studied, CTPsyn func tions have never been linked to mitochondrial respiration (33) . Because CTP is a precursor required for the metabolism of DNA, RNA, and phospholipids, it would be interesting to test whether the reduction of CTPsyn affects these processes in mitochondria. CTP:phosphoethanolamine cytidylyltransferase (PCYT2) is a ratelimiting enzyme that uses CTP as a precursor to synthesize cytidine diphosphate (CDP)-ethanolamine Kennedy pathway in termediates. It has been shown that inhibition of PCYT2 results in the buildup of its substrate, phosphoethanolamine (PEtn), which di rectly inhibits mitochondrial respiration (34) . The synthesis of other phospholipids such as cardiolipin, a mitochondriaspecific phospho lipid, also requires CTP (35) . Determining whether the mitochon drial defects in CTPsyn RNAi tissues were due to the accumulation of PEtn or the lack of key phospholipids such as cardiolipin requires further investigation.
In this screen, we found that four of five genes participating in the catabolism of tyrosine were required for the maintenance of proper mitochondrial morphology. The reduction in these genes' expression led to the fragmentation of the mitochondria, a phenotype that usually results from the increase in mitochondrial fission or the reduction of mitochondrial fusion. Tyrosine is an aromatic amino acid impor tant in the synthesis of thyroid hormones, catecholamines, and mela nin. The end products of tyrosine catabolism are acetoacetate and fumarate, two molecules that can then enter into the citric acid cycle. How the lack of these enzymes led to misregulation of mitochondrial morphology requires elucidation. Impaired catabolism of tyrosine is a feature of several acquired and genetic disorders. It would be inter esting to evaluate whether there is a mitochondrial defect in those patients.
Notably, knocking down genes encoding proteins belonging to the same complex sometime causes different mitochondrial pheno types, which is consistent with the phenotypic heterogeneity observed in diseases that are caused by mutations in different nuclearencoded mitochondrial genes. There are several potential explanations for these phenomena: (i) For the genes working in the same pathway, some of them might be positive regulators and others might be neg ative regulators; therefore, their effects could be different. (ii) Even the factors work in the same pathway and regulate the process in the same direction, and the RNAi or mutation of these genes might cause different effects. For example, the reduction of one gene could lead to the increase in activity of another gene product in the same pathway. Therefore, interpreting a phenotype needs a casebycase analysis. (iii) Although some gene products work in the same pathway, each gene could have its own specific functions independent on its func tions in this pathway.
Mitochondria have diverse morphology in different tissues. However, their regulations were largely conserved. The tissue specific regulators of mitochondrial morphology usually have tissuespecific expression pattern, such as fzo (36) . In this study, we used fly fat body as a model system to identify the regulators for mitochondrial morphology. Some regulators that we identified here might have tissuespecific functions. Because most hits have broad expression patterns, most of them likely play similar roles in other tissues.
In this study, we found that the lack of Dhpr led to muscle de generation, TH neuron loss, and locomotive defects that were very similar to those observed with the loss of Pink1/park. In some pa tients, Dhpr mutation causes movement disorders and psychiatric disorders similar to PD (37) . Dhpr is the key enzyme that catalyzes the recycling of BH4, a cofactor required for DOPA synthesis. The loss of Dhpr leading to mitochondrial defects was an unexpected result. Mitochondria became swollen and had less cristae. We found that the catalytic activity of Dhpr is critical for its mito chondrial functions. Further reduction of BH4 by knocking down the expression of Pu, the key enzyme for de novo BH4 biosynthesis, enhanced the mitochondrial defects caused by the reduction of Dhpr. The lack of obvious mitochondrial phenotypes for Pu RNAi alone tissues is probably due to insufficient knockdown efficiency. BH4 functions as a cofactor to produce NO and synthesizes the precursors of dopamine and serotonin. We found that the reduc tion of Nos, the NO synthase, but not hn, ple, or Trh, could en hance the mitochondrial defects caused by Dhpr RNAi. In addition, the loss of Dhpr reduced the Snitrosylation of Drp1, a modification mediated by NO. This suggests that Dhpr probably regulates Drp1 activity by modulating NO synthesis ( fig. S10 ). Snitrosylation is frequently dysregulated in disease and aging (38) . The steadystate concentration of protein Snitrosylation was main tained by the equilibration between the rates of Snitrosylation and denitrosylation of the protein. The excessive Snitrosylation of Drp1 could be induced by amyloid (A) protein oligomers and other pathological conditions (39) . Our data suggested that certain amount of Drp1 Snitrosylation is required during phys iological conditions. The RNAi of Nos alone only reduces the Nos RNA level by 40% ( fig. S9P ), which may explain why there are no obvious mitochondrial defects in the Nos RNAi alone tissues. Mutation on the Snitrosylation site of Drp1 abolished Drp1 ac tivity, suggesting that this modification is critical. It is possible that the ectopically expressed Drp1 could still be modified by NO produced by the remaining Dhpr activity in Dhpr RNAi tissues. Our data also suggested that Pink1/park probably functions in parallel with Dhpr. Pink1 or park overexpression partially rescued Dhpr RNAiinduced mitochondrial defects, probably by affecting mitochondrial fusion and fission or regulating mitophagy ( fig. S10 ). Further efforts are needed to dissect whether Dhpr participates in mitophagy under physical conditions. The reduction of Dhpr activ ity leads to multiple human diseases. It would be interesting to investigate whether mitochondrial defects contribute to disease progression and whether increasing Drp1 or Pink1/Parkin activity could be beneficial treatments.
MATERIAL AND METHODS
Fly strains and RNAi screen strategies
The transgenic RNAi files were ordered from TsingHua Fly Center (THFC; Beijing, China), which is the same RNAi collection as the TRiP collection. Marf (BL: 31157), Pink1 (BL: 31170), and park (BL: 31259) RNAi lines were missing in THFC collections; we therefore ordered those lines from Bloomington Drosophila Stock Center (BDSC) and mixed them into the collection, coded them randomly, and screened them without knowing the genotypes. The other fly strains used in this study were UAS-Drp1 (BL: 51647), UAS-Pink1 (BL: 51648), UAS-ManII-GFP, UAS-GFP-SKL (BL: 28881), UAS-RFP-KDEL (BL: 30909), UAS-MitoGFP (BL: 8442), UAS-Dcr-2 (BL: 24650), gstD1-GFP, Cg-Gal4 (BL: 7011), Ple-Gal4 (BL: 8848), Mef2-Gal4 (BL: 27390), and Pink1 [B9] (BL: 34749). The mutant Dhpr (Dhpr and Dhpr 42-5 ) lines were generated by using the CRISPRCas9 technique.
All the flies were raised in a humidified, temperaturecontrolled incubator (25°C). Two to three males carrying Cg-Gal4 divers were crossed to about 15 virgin females carrying UAS-RNAi transgenes. Six hours after egg laying, flies were transferred to fresh food and the eggs were cultured in the incubator for 90 hours. Fat body tissues were dissected for further analysis.
The screen was conducted in three rounds in a double blind man ner. For the first two rounds, at least two biological replicas for each genotype were examined each time. The hits from the first round were retested by independent researchers in the second round. For some samples, if the results from the first and second rounds are different, the thirdround analysis was done and at least four biological repli cas were examined. Only the ones that have been confirmed twice to have aberrant mitochondrial morphology during the screen were listed as positive hits.
Molecular cloning
Drp1 cDNA was cloned into the pUAS attB vector with a Cterminal 3× HA tag. Dhpr cDNA was cloned into the pUAS attB vector with a Cterminal V5 tag. Dhpr G16D and Drp1 C643A expressing vectors were generated by sitedirected mutagenesis. Park cDNA was cloned into the pUAS attB vector with a Cterminal V5 tag. Marf cDNA was cloned into the pUAS attB vector with a Cterminal 6× Myc tag. QDPR cDNA was cloned into the pEGFPN1 vector. To generate Dhpr genomic rescue construct, Dhpr genomic DNA fragment with its upstream and downstream 1kb sequences were cloned into the pattB vector, and a V5 tag was inserted before the stop codon of Dhpr coding sequence.
Biotin-switch assay
To analyze the level of SNODrp1, the biotinswitch assay was per formed as described previously (40) . Briefly, the adult fly thoraxes were dissected and homogenized in HEN buffer [250 mM Hepes NaOH (pH 7.7), 1 mM EDTA, and 0.1 mM neocuproine]. Then, the free thiols in the tissue extracts were blocked with 20 mM methyl methanethiosulfonate (64306, Sigma) for 20 min at 50°C, and tissue extracts were precipitated with acetone. The pellets were harvested and resuspended in HEN buffer with 1% SDS. SNO was selectively reduced by ascorbate to reform the thiol group and subsequently biotinylated with N[6(biotinamido)hexyl]3′(2′pyridyldithio) propionamide] (A35390, Thermo Fisher Scientific). The biotinylated proteins were pulled down with streptavidinagarose beads (S1638, Sigma). Drp1 was detected by Western blotting with antiDrp1 anti body (8570S, Cell Signaling Technology). Drp13HA and Drp1 C643A 3HA were detected by Western blotting with antiHA antibody (3724S, Cell Signaling Technology). Relative levels of Snitrosylated proteins were determined by a comparison of Snitrosylated Drp1 to the total amount of Drp1 in the extract for each sample.
Bioinformatic analysis and statistics
We queried available databases that contained information on protein protein interactions, genetic interactions, twohybrid interactions, text mining, and other data. We further used the online software COMPLEAT and the KEGG pathway analysis to identify the pro tein complexes (18) . We also performed extensive data mining and manually added proteins missed in the COMPLEAT analysis into complexes.
The classification of hits was judged by the similarity of the mito chondrial morphology, complex analysis, and genetic network. According to precious studies (18), complex analysis was performed by using the online software COMPLEAT (www.flyrnai.org/ compleat/). Using COMPLEAT, 312 nonredundant protein complexes overrepresented among the genes were scored comparing to the ex perimental background with a P value cutoff of 0.05. An interaction matrix was first established among all genes scored in the screen, and then the resulting network was visualized by the software Cytoscape.
The statistical analysis was performed using Prism 5 (GraphPad). The results were analyzed by the twotailed unpaired Student's t test, oneway ANOVA/Bonferroni's multiple comparisons test,  2 (and Fisher's exact) test, and logrank test, as indicated in the figure leg ends. All the results were presented as mean values + SEM. A P value of <0.05 was considered statistically significant.
For confidence of identified genes from the screen, if the RNAi lines were predicted with no offtarget effects or if two or more in dependent RNAi lines have similar phenotypes, we considered the genes to be highconfidence hits. If the RNAi lines were predicted with potential offtarget effects or phenotypes only exist in one RNAi line but not in the other, and the corresponding genes were co complexed with highconfidence hits, we considered the genes to be mediumconfidence hits. If the RNAi lines were predicted with potential offtarget effects and the gene is not cocomplex with high confidence hits, we considered them as lowconfidence hits. The con fidence of identified genes is listed in table S2.
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